Company / Current Liabilities
Processa Pharmaceuticals, Inc. Current Liabilities History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$998.6K
FY2022
5-year range
$840.1K / $2.4M
FY2018-FY2022
Trend
+2.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 6 years, ranging from $840,053 in FY2014 to $2M in FY2016.
Based on SEC 10-K filings.
$998,556 in FY2022.
Improved from $2M to $998,556 over the past 6 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities increased 2.8% year-over-year.
- Peak current liabilities was recorded in FY2016.
- Lowest current liabilities in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $998.6K | +2.8% |
| FY2021 | $971.0K | -58.8% |
| FY2016 | $2.4M | +13.0% |
| FY2015 | $2.1M | +148.0% |
| FY2014 | $840.1K | -25.1% |
| FY2013 | $1.1M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026